Skip to content

GWAS Research of Lung Cancer in Tianjin

GWAS Research of Lung Cancer by Department of Epidemiology and Biostatistics in Tianjin Medical University Cancer Institute and Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01255059
Enrollment
500
Registered
2010-12-07
Start date
2010-06-30
Completion date
2016-12-31
Last updated
2015-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small Cell Lung Cancer, Primary Carcinoma

Keywords

Genome-wide association studies(GWAS), Single nucleotide polymorphism(SNP), Lung cancer

Brief summary

To study the association of Genetic Polymorphisms with Lung Cancer Risk in Tianjin Population.

Detailed description

Eligibility criteria: * nonsmoker * female * age between 35 and 80 * no other types of tumors history * frequency-matched cases and controls on gender and age Outcome measures: * OR(odds ratio) * RR(risk ratio) * CI(confidence interval) * SAS software

Interventions

None listed

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Non-small cell lung cancer * Age from 35 to 80 years old * Female * Non-smokers * Frequency-matched on age and gender

Exclusion criteria

* Previous medical history of cancer * Previous radiotherapy * Previous chemotherapy

Design outcomes

Primary

MeasureTime frameDescription
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia2011-12A GWAS reported a novel association between the TP63 locus and risk of lung adenocarcinoma; however, this association did not achieve genome-wide significance among never-smoking males or females. We genotyped the TP63 SNPs reported by the previous GWAS (rs10937405 and rs4488809) in 500 never-smoking female lung cancer cases and 500 never-smoking female controls from China. Genetic variation in rs10937405 was associated with lung adenocarcinoma. Our findings provide strong evidence that genetic variation in TP63 is associated with risk of lung adenocarcinoma among non-smoking females.

Countries

China

Contacts

Primary ContactChen Kexin, M.D., Ph.D
chenkexin1963@yahoo.com0086-022-23372231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026